Temat: "Cisplatin" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression.
Autorzy:: Pan R; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Wang R; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Cheng F; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Wang L; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Cui Z; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
She J; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Yang X; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China. .; Pokaż więcej
Źródło:: Reproductive biology and endocrinology : RB&E [Reprod Biol Endocrinol] 2024 Apr 11; Vol. 22 (1), pp. 41. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Ferroptosis*
Female ; Humans ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; Granulosa Cells/metabolism ; Stem Cells/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Transcriptomic Changes in Cisplatin-Resistant MCF-7 Cells.
Autorzy:: Ruiz-Silvestre A; Laboratorio de Epigenetica, Instituto Nacional de Medicina Genomica (INMEGEN), Ciudad de Mexico 14610, Mexico.; Posgrado en Ciencias Biomédicas, Universidad Nacional Autónoma de Mexico (UNAM), Ciudad de Mexico 04510, Mexico.
Garcia-Venzor A; Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.
Ceballos-Cancino G; Laboratorio de Genomica Funcional del Cancer, Instituto Nacional de Medicina Genomica (INMEGEN), Ciudad de Mexico 14610, Mexico.
Sánchez-López JM; Laboratorio de Epigenetica, Instituto Nacional de Medicina Genomica (INMEGEN), Ciudad de Mexico 14610, Mexico.
Vazquez-Santillan K; Laboratorio de Innovación en Medicina de Precisión, Instituto Nacional de Medicina Genomica (INMEGEN), Ciudad de Mexico 14610, Mexico.
Mendoza-Almanza G; Laboratorio de Epigenetica, Instituto Nacional de Medicina Genomica (INMEGEN), Ciudad de Mexico 14610, Mexico.; Consejo Nacional de Ciencia y Tecnologia, Ciudad de Mexico 03940, Mexico.
Lizarraga F; Laboratorio de Epigenetica, Instituto Nacional de Medicina Genomica (INMEGEN), Ciudad de Mexico 14610, Mexico.
Melendez-Zajgla J; Laboratorio de Genomica Funcional del Cancer, Instituto Nacional de Medicina Genomica (INMEGEN), Ciudad de Mexico 14610, Mexico.
Maldonado V; Laboratorio de Epigenetica, Instituto Nacional de Medicina Genomica (INMEGEN), Ciudad de Mexico 14610, Mexico.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 29; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Transcriptome*
Cisplatin*/pharmacology
Female ; Humans ; MCF-7 Cells ; Gene Expression Profiling ; DNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background.
Autorzy:: Chiappa M; Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via M. Negri 2, 20156 Milan, Italy.
Guffanti F; Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via M. Negri 2, 20156 Milan, Italy.
Grasselli C; Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via M. Negri 2, 20156 Milan, Italy.
Panini N; Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via M. Negri 2, 20156 Milan, Italy.
Corbelli A; Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via M. Negri 2, 20156 Milan, Italy.
Fiordaliso F; Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via M. Negri 2, 20156 Milan, Italy.
Damia G; Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via M. Negri 2, 20156 Milan, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 06; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Ovarian Neoplasms*/metabolism
Humans ; Female ; Animals ; Mice ; Platinum ; Neoplasm Recurrence, Local ; Homologous Recombination ; Drug Resistance, Neoplasm ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: TonEBP/NFAT5 expression is associated with cisplatin resistance and migration in macrophage-induced A549 cells.
Autorzy:: Song HJ; Department of Physiology, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Kim YH; Department of Physiology, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Choi HN; Department of Physiology, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Kim T; Department of Physiology, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Kim SJ; Department of Physiology, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Kang MW; Department of thoracic surgery, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
Lee SD; Department of Physiology, Chungnam National University College of Medicine, Daejeon, Republic of Korea. .; Pokaż więcej
Źródło:: BMC molecular and cell biology [BMC Mol Cell Biol] 2024 Mar 04; Vol. 25 (1), pp. 6. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Lung Neoplasms*/drug therapy
Humans ; NF-kappa B ; A549 Cells ; Transcription Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1.
Autorzy:: Bork T; Department of Medicine IV, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Hernando-Erhard C; Department of Medicine IV, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Liang W; Department of Medicine IV, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430064, China.
Tian Z; Department of Nephrology and Hypertension, Hannover Medical School, 30625 Hannover, Germany.
Yamahara K; Department of Medicine IV, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Department of Medicine, Shiga University of Medical Science, Tsukinowa-cho, Otsu 520-2192, Shiga, Japan.
Huber TB; III Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 22; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Acute Kidney Injury*/metabolism
Mice ; Animals ; Beclin-1/metabolism ; Autophagy ; Apoptosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.
Autorzy:: Rossini E; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Tamburello M; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Abate A; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Zini S; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Ribaudo G; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Gianoncelli A; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Calza S; Unit of Biostatistics and Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Valcamonico F; Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Suardi NR; Urology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Mirabella G; Urology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Berruti A; Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Sigala S; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.; Pokaż więcej
Źródło:: Cells [Cells] 2024 Feb 20; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Testicular Neoplasms*
Cyclic N-Oxides*
Indolizines*
Neoplasms, Germ Cell and Embryonal*
Pyridinium Compounds*
Male ; Animals ; Humans ; Zebrafish ; Cell Proliferation ; Protein Kinase Inhibitors/pharmacology
SCR Disease Name:: Testicular Germ Cell Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Cisplatin Toxicity Causes Neutrophil-Mediated Inflammation in Zebrafish Larvae.
Autorzy:: Padovani BN; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.
Morales Fénero C; Department of Microbiology and Environmental Toxicology, Biomedical Sciences, University of California Santa, Santa Cruz, CA 95064, USA.
Paredes LC; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.
Amaral MAD; Nephrology Division, Department of Medicine, Federal University of Sao Paulo, São Paulo 04023062, Brazil.
Domínguez-Amorocho O; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.
Cipelli M; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.
Gomes JMM; Department of Developmental & Molecular Biology, Albert Einstein College of Medicine, New York, NY 10461, USA.
da Silva EM; Nephrology Division, Department of Medicine, Federal University of Sao Paulo, São Paulo 04023062, Brazil.
Silva LM; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.
Vieira RS; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.
Pereira MT; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.
Cruz MC; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.
Câmara NOS; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508000, Brazil.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 17; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/toxicity
Cisplatin*/metabolism
Acute Kidney Injury*/metabolism
Animals ; Zebrafish ; Neutrophils/metabolism ; Larva ; Inflammation/chemically induced ; Inflammation/metabolism ; Cytokines/metabolism ; Mammals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target.
Autorzy:: Li W; Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital, Children's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530002, China.
Huang L; Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital, Children's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530002, China.
Qi N; Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital, Children's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530002, China.
Zhang Q; Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital, Children's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530002, China. .
Qin Z; Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital, Children's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530002, China. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2024 Feb 16; Vol. 25 (1), pp. 183. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Female ; Humans ; Calmodulin-Binding Proteins/genetics ; Calmodulin-Binding Proteins/metabolism ; Drug Resistance, Neoplasm/genetics ; Neoplasm Recurrence, Local ; Platinum/pharmacology ; Platinum/therapeutic use ; Prognosis ; Up-Regulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Activation of S1P 2 is protective against cisplatin-induced peripheral neuropathy.
Autorzy:: Lam BWS; Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Xiang P; Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Peng B; Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Soon LJJ; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Yam ATY; Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Lim CMH; Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Zheng Y; Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Nguyen LN; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Singapore Lipidomics Incubator (SLING), Life Sciences Institute, National University of Singapore, Singapore, Singapore.; Cardiovascular Disease Research (CVD) Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Herr DR; Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Translational Neuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Le MTN; Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Immunology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Pokaż więcej
Źródło:: Cell proliferation [Cell Prolif] 2024 Feb; Vol. 57 (2), pp. e13549. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:: Letter
MeSH Terms:: Cisplatin*/adverse effects
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/drug therapy
Peripheral Nervous System Diseases*/prevention & control
Humans ; Signal Transduction

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Role of Epigenetics for the Efficacy of Cisplatin.
Autorzy:: Lumpp T; Department Food Chemistry and Toxicology, Institute of Applied Biosciences, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.
Stößer S; Department Food Chemistry and Toxicology, Institute of Applied Biosciences, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.
Fischer F; Department Food Chemistry and Toxicology, Institute of Applied Biosciences, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.
Hartwig A; Department Food Chemistry and Toxicology, Institute of Applied Biosciences, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.
Köberle B; Department Food Chemistry and Toxicology, Institute of Applied Biosciences, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 17; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Neoplasms*/drug therapy
Neoplasms*/genetics
Humans ; Platinum ; Epigenesis, Genetic ; DNA Methylation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells.
Autorzy:: Shi H; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.; Kunming Medical University, Kunming, China.
Tan Z; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.; Kunming Medical University, Kunming, China.
Duan B; Kunming Medical University, Kunming, China.
Guo C; School for Life Science, Yunnan University, Kunming, China.
Li C; Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Luan T; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.
Li N; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.
Huang Y; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.
Chen S; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.; Kunming Medical University, Kunming, China.
Gao J; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.; Kunming Medical University, Kunming, China.
Feng W; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.; Kunming Medical University, Kunming, China.
Xu H; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.; Kunming Medical University, Kunming, China.
Wang J; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Yunnan Clinical Medical Center of Urological Disease, Kunming, China.
Fu S; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China. .; Yunnan Clinical Medical Center of Urological Disease, Kunming, China. .
Wang H; Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China. .; Yunnan Clinical Medical Center of Urological Disease, Kunming, China. .; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2024 Jan 09; Vol. 22 (1), pp. 19. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Sphingosine N-Acyltransferase*/metabolism
Humans ; Apoptosis ; beta Catenin ; Animals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Effects of Nutraceuticals on Cisplatin-Induced Cytotoxicity in HEI-OC1 Cells.
Autorzy:: Guidotti L; General Physiology Unit, Department of Biology, University of Pisa, Via San Zeno 31, 56127 Pisa, Italy.
Tomassi E; Institute of Agricultural Biology and Biotechnology, Italian National Research Council, Via Moruzzi 1, 56124 Pisa, Italy.
Marracci S; General Physiology Unit, Department of Biology, University of Pisa, Via San Zeno 31, 56127 Pisa, Italy.
Lai M; Retrovirus Centre, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, Strada Statale del Brennero 2, 56127 Pisa, Italy.
Lapi D; General Physiology Unit, Department of Biology, University of Pisa, Via San Zeno 31, 56127 Pisa, Italy.
Pesi R; Biochemistry Unit, Department of Biology, University of Pisa, Via San Zeno 31, 56127 Pisa, Italy.
Pucci L; Institute of Agricultural Biology and Biotechnology, Italian National Research Council, Via Moruzzi 1, 56124 Pisa, Italy.
Novellino E; Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
Albi E; Department of Pharmaceutical Sciences, Interno Orto Botanico, University of Perugia, Via Romana, 06126 Perugia, Italy.
Garcia-Gil M; General Physiology Unit, Department of Biology, University of Pisa, Via San Zeno 31, 56127 Pisa, Italy.; Interdepartmental Research Center Nutrafood 'Nutraceuticals and Food for Health', University of Pisa, 56124 Pisa, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 12; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/metabolism
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/metabolism
Antioxidants/pharmacology ; Reactive Oxygen Species/metabolism ; Sphingomyelin Phosphodiesterase/metabolism ; Hair Cells, Auditory/metabolism ; Apoptosis ; Caspases/metabolism ; Dietary Supplements ; Cell Survival

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in Lung Cancer.
Autorzy:: Geng P; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.
Zhao J; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.
Li Q; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.
Wang X; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.
Qin W; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.
Wang T; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.
Shi X; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.
Liu X; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.
Chen J; CAS Key Laboratory of Chemistry of Northwestern Plant Resources, Key Laboratory for Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
Qiu H; CAS Key Laboratory of Chemistry of Northwestern Plant Resources, Key Laboratory for Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
Xu G; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.; Liaoning Province Key Laboratory of Metabolomics, Dalian 116023, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 01; Vol. 24 (23). Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Humans ; 4-Butyrolactone/pharmacology ; Phospholipids/pharmacology ; Drug Resistance, Neoplasm/genetics ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Therapeutic effect of sodium alginate on bleomycin, etoposide and cisplatin (BEP)-induced reproductive toxicity by inhibiting nitro-oxidative stress, inflammation and apoptosis.
Autorzy:: Moradi M; Department of Clinical Sciences, Faculty of Veterinary Medicine, Razi University, Kermanshah, Iran.; Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Hashemian MA; Department of Clinical Sciences, Faculty of Veterinary Medicine, Razi University, Kermanshah, Iran.
Faramarzi A; Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. .; Department of Anatomical Sciences, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran. .
Goodarzi N; Department of Basic and Pathobiological Sciences, Faculty of Veterinary Medicine, Razi Universtiy, Kermanshah, Iran. .
Hashemian AH; Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.; Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Cheraghi H; Department of Clinical Sciences, Faculty of Veterinary Medicine, Razi University, Kermanshah, Iran.
Jalili C; Department of Anatomical Sciences, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran.; Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Jan 18; Vol. 14 (1), pp. 1565. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/toxicity
Cisplatin*/metabolism
Testicular Neoplasms*/pathology
Humans ; Male ; Rats ; Animals ; Etoposide/pharmacology ; Bleomycin/toxicity ; Bleomycin/metabolism ; Antioxidants/metabolism ; Alginates/pharmacology ; Alginates/therapeutic use ; Tumor Necrosis Factor-alpha/metabolism ; Tumor Suppressor Protein p53/metabolism ; bcl-2-Associated X Protein/metabolism ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Semen/metabolism ; Testosterone/metabolism ; Oxidative Stress ; Apoptosis ; Inflammation/chemically induced

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistance.
Autorzy:: Manzoor HB; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
Asare-Werehene M; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.; Department of Obstetrics & Gynecology, & The Centre for Infection, Immunity and Inflammation (CI3), Faculty of Medicine & Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, ON, K1H 8L1, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Pereira SD; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
Satyamoorthy K; Shri Dharmasthala Manjunatheshwara University, Manjushree Block, Manjushree Nagar Sattur, Dharwad, Karnataka, 580 009, India.
Tsang BK; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada. .; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada. .; Department of Obstetrics & Gynecology, & The Centre for Infection, Immunity and Inflammation (CI3), Faculty of Medicine & Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, ON, K1H 8L1, Canada. .; Pokaż więcej
Źródło:: Journal of ovarian research [J Ovarian Res] 2024 Jan 12; Vol. 17 (1), pp. 15. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Humans ; Female ; Gelsolin/genetics ; Gelsolin/metabolism ; DNA Methylation ; Epigenesis, Genetic ; Drug Resistance, Neoplasm/genetics ; RNA, Messenger/metabolism ; Mixed Function Oxygenases/genetics ; Mixed Function Oxygenases/metabolism ; Mixed Function Oxygenases/therapeutic use ; Proto-Oncogene Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Adipose Stromal Cell-Derived Secretome Attenuates Cisplatin-Induced Injury In Vitro Surpassing the Intricate Interplay between Proximal Tubular Epithelial Cells and Macrophages.
Autorzy:: Rendra E; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, 68167 Mannheim, Germany.
Uhlig S; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, 68167 Mannheim, Germany.; Flow Core Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Moskal I; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, 68167 Mannheim, Germany.
Thielemann C; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, 68167 Mannheim, Germany.
Klüter H; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, 68167 Mannheim, Germany.; Mannheim Institute for Innate Immunoscience, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Bieback K; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, 68167 Mannheim, Germany.; Flow Core Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Mannheim Institute for Innate Immunoscience, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Pokaż więcej
Źródło:: Cells [Cells] 2024 Jan 09; Vol. 13 (2). Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cisplatin*/pharmacology
Secretome*
Epithelial Cells ; Macrophages ; Culture Media, Conditioned/pharmacology ; Stromal Cells ; Cytokines

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Modulation of Cisplatin Sensitivity through TRPML1-Mediated Lysosomal Exocytosis in Ovarian Cancer Cells: A Comprehensive Metabolomic Approach.
Autorzy:: Kim B; Department of SmartBio, College of Life and Health Science, Kyungsung University, Busan 48434, Republic of Korea.
Kim G; Department of SmartBio, College of Life and Health Science, Kyungsung University, Busan 48434, Republic of Korea.
Kim H; WCU Biomodulation, Department of Agricultural Biotechnology, Seoul National University, Seoul 08826, Republic of Korea.; Cancer Research Institute, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Song YS; WCU Biomodulation, Department of Agricultural Biotechnology, Seoul National University, Seoul 08826, Republic of Korea.; Cancer Research Institute, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Jung J; Department of SmartBio, College of Life and Health Science, Kyungsung University, Busan 48434, Republic of Korea.; Pokaż więcej
Źródło:: Cells [Cells] 2024 Jan 08; Vol. 13 (2). Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cisplatin*/pharmacology
Exocytosis*
Ovarian Neoplasms*/drug therapy
Female ; Humans ; Lysosomes/metabolism ; Transient Receptor Potential Channels/metabolism ; Drug Resistance, Neoplasm/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Histone acetylation: a key determinant of acquired cisplatin resistance in cancer.
Autorzy:: Natu A; Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, MH, 410210, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, MH, 400094, India.
Verma T; Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, MH, 410210, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, MH, 400094, India.
Khade B; Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, MH, 410210, India.
Thorat R; Laboratory Animal Facility, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, 410210, India.
Gera P; Biorepository, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, 410210, India.
Dhara S; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, MH, 400094, India.; Fuel Chemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India.
Gupta S; Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, MH, 410210, India. .; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, MH, 400094, India. .; Pokaż więcej
Źródło:: Clinical epigenetics [Clin Epigenetics] 2024 Jan 03; Vol. 16 (1), pp. 8. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cisplatin*/pharmacology
Neoplasms*/drug therapy
Neoplasms*/genetics
Humans ; Histones/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Epigenesis, Genetic ; Acetylation ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Drug Resistance, Neoplasm/genetics ; Cell Line, Tumor ; DNA Methylation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Short-term autophagy inhibition by autophinib or SAR405 does not alter the effect of cisplatin on ATP production in prostate cancer cells.
Autorzy:: Kratochvilova M
Stepka P
Raudenska M
Balvan J
Richtera L
Cernei N
Skopalova DS
Zitka O
Filipensky P
Babula P
Masarik M; Pokaż więcej
Źródło:: Bratislavske lekarske listy [Bratisl Lek Listy] 2024; Vol. 124 (2), pp. 84-91.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/pathology
Pyrazoles*
Pyridines*
Pyrimidines*
Pyrimidinones*
Male ; Humans ; Autophagy ; Cell Line, Tumor ; Amino Acids/pharmacology ; Amino Acids/metabolism ; Adenosine Triphosphate/pharmacology ; Arginine

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer.
Autorzy:: Zhang M; Department of Gynecology, The Third Affiliated Hospital of Zhengzhou University, 7 Rehabilitation Front Street, Zhengzhou, 450052, China.
Wang J; Department of Orthopedics, Xuanwu Hospital, Capital Medical University, Beijing, 100000, China.
Guo Y; Department of Oncology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, No. 7 Weiwu Street, Zhengzhou, 450003, China. .
Yue H; Department of Center for Clinical Single Cell Biomedicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, No. 7 Weiwu Street, Zhengzhou, 450003, China. .
Zhang L; Department of Gynecology, The Third Affiliated Hospital of Zhengzhou University, 7 Rehabilitation Front Street, Zhengzhou, 450052, China. .; Pokaż więcej
Źródło:: Journal of ovarian research [J Ovarian Res] 2023 Dec 19; Vol. 16 (1), pp. 240. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/metabolism
Animals ; Mice ; Humans ; Female ; Proto-Oncogene Proteins c-akt/metabolism ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Mice, Nude ; Cell Line, Tumor ; Signal Transduction ; TOR Serine-Threonine Kinases/metabolism ; Autophagy/genetics ; Cell Proliferation/genetics ; Drug Resistance, Neoplasm/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Cisplatin"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji